Recherche

What is obesity? Being overweight or obese is defined as having an abnormal or excessive accumulation of fat that is harmful to health. The World Health Organisation (WHO) considers that a person is overweight when their body mass index (BMI) is above 25 and is obese when it is equal to or above 30.  In Belgium, 49.3% of the adult population is overweight and 16% of the population is obese. The risk of being overweight or obese increases with age as it applies to one third and one fifth of the population respectively after the age of 35.  It is a public health problem associated with the development of numerous diseases such as high blood pressure and diabetes.     Care The Erasmus Hospital Integrated Obesity Centre (CIO)  proposes three care modules for persons who are overweight or obese: intensive coaching, medical interventions (including intergastric balloon or gastric pication) and surgery. Each module is personalised for each patient. As a patient at the CIO you are at the heart of a multidisciplinary team of experts in which you are the key actor in your own care. At each stage you will be accompanied by a team of dieticians, psychologists, endocrinologists, nutritionist doctors, gastroenterologists, surgeons and physiotherapists.    The Integrated Obesity Centre is associated with the Multidisciplinary Obesity Centre for Children located on the HUDERF Campus  that is dedicated to caring for children and adolescents.  These young people receive, on the basis of a medical convention,  multidisciplinary and structured care that is adapted to their needs.    Image Research The treatment of obesity, for adults and children, is constantly evolving.    There are numerous research projects in this area, ranging from theses on dietetics (including in children), physiotherapy, psychology and medicine to drug studies and academic studies. The Integrated Obesity Centre and Multidisciplinary Obesity Centre for Children aim to be at the forefront of research and teaching.   

Our role Ophthalmology is the medical speciality concerned with the eyes. Our aim is to improve visual health and treat eye disease. Image "Our care is comprehensive: from screening to medical and/or surgical treatment. The academic aspect is and must remain central. We have doctors who are experts in modern treatments designed for all stages of life."  Our specialities The Ophthalmology Department is subdivided into a number of elements: The Orbito-Palpebro-Lacrymal and Onco-Ophthalmology Clinic is concerned with problems of the eye socket, eyelids, tear glands and ducts as well as with the orbital mass.    The Glaucoma Clinic is recognised nationally for its expertise; patients are referred to this clinic from throughout Belgium. The Paediatric Ophthalmology Clinic prevents, screens for and treats eye problems in children.  Examples: refraction problems (myopia, hypermetropia and astigmatism), strabism, amblyopia, eye development anomalies, infectious diseases, etc. Corneal medical treatment proposes a range of treatment to stabilise and/or treat degenerative or progressive diseases on the surface of the eye. Corneal surgery is fast developing and carries out all available cornea grafts. Refractive surgery seeks to dispense with optical corrections such as spectacles or contact lenses.    Retinal medical treatment is concerned with pathologies such as age-associated wet or dry macular degeneration (AMD). Retinal surgery is used, for example, to correct detached retinas or to place or change intraocular transplants, etc. Neuro-ophthalmology treats disorders of the optic nerves and all the various ocular disorders associated with a neurological pathology (SEP, stroke, brain tumour, etc.) Some diseases (diabetes, tuberculosis, Sjögren's syndrome, etc.) can affect the eyes and threaten vision. This is why the Ophthalmology Department cooperates with other departments such as endocrinology, rheumatology, paediatrics, haematology, etc.  Our team Image Our medical specialists Research The ophthalmologists at the Erasmus Hospital carry out clinical studies and fundamental research, on: vitreoretinal proliferation, in collaboration with the ULB's Laboratory of Physiopathological and Nutritional Biochemistry (LBPN);cornea cells, in collaboration with the Jules Bordet Institute's Cell Therapy Laboratory. Focus Every year the Ophthalmological Department carries out approximately 2,000 intravitreal injections. This type of treatment can be indicated to treat age-related macular degeneration (AMD), retinopathies associated with diabetes, intraocular inflammation, etc.  Publications Lien vers Array Neuro-Ophthalmological Manifestations in Children with Down Syndrome: Current Perspectives Auteurs : Lavinia Postolache 1, Anne Monier 2, Sophie Lhoir 1Journal : Eye Brain 2021 Jul 21;13:193-203. doi: 10.2147/EB.S319817. eCollection 2021. 10 August 2023 Lien vers Array Intense Pulsed Light Therapy in the Treatment of Dry Eye Diseases: A Systematic Review and Meta-Analysis. Auteurs : Demolin L, Es-Safi M, Soyfoo MS, Motulsky E.Journal : J Clin Med. 2023 Apr 21;12(8):3039. doi: 10.3390/jcm12083039.PMID: 37109374 10 August 2023 Lien vers Array Experimental Models to Study Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy. Auteurs : Datlibagi A, Zein-El-Din A, Frohly M, Willermain F, Delporte C, Motulsky E.Journal : Int J Mol Sci. 2023 Feb 24;24(5):4509. doi:  10.3390/ijms24054509.PMID: 36901938 10 August 2023 Lien vers Array Visual field defects and retinal nerve fiber layer damage in buried optic disc drusen: a new insight. Auteurs : Nana Wandji B, Dugauquier A, Ehongo A.Journal : Int J Ophthalmol. 2022 Oct 18;15(10):1641-1649. doi: 10.18240/ijo.2022.10.12. eCollection 2022. PMID: 36262850 10 August 2023